Targeting M1/M3 Muscarinic Receptors to Treat Gestational Pesticide Poisoning
靶向 M1/M3 毒蕈碱受体治疗妊娠期农药中毒
基本信息
- 批准号:10320743
- 负责人:
- 金额:$ 53.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAcetylcholinesteraseAcuteAddressAftercareAgeAgonistAmygdaloid structureAnimal ModelAnimalsAnti-Inflammatory AgentsAntidotesAtropineBehavioralBrainCaviaCellsChemicalsChlorpyrifosCholinergic ReceptorsCognitive deficitsCorpus striatum structureDependenceDevelopmentDoseDystoniaEffectivenessElectroencephalographyEnzyme-Linked Immunosorbent AssayEquilibriumExposure toFeedbackFemaleFetal healthFetusFrequenciesHealthHippocampus (Brain)HistologicImmunohistochemistryInflammationIntoxicationLifeLightMagnetic Resonance ImagingMaternal HealthMaternal MortalityMedicalMicrogliaMonitorMorbidity - disease rateMothersMuscarinic Acetylcholine ReceptorMuscarinic M2 ReceptorMuscarinic M3 ReceptorNervous system structureNeurogliaNeurologicNeuronsNicotinic ReceptorsOralOutcomeParkinson DiseasePatternPersonsPesticidesPharmaceutical PreparationsPharmacologyPlacebo ControlPlacentaPoisonPoisoningPopulationPregnancyPreventionPublic HealthRandomizedRestReverse Transcriptase Polymerase Chain ReactionRisk AssessmentSecuritySeizuresSpontaneous abortionTelemetryTerrorismTestingTherapeuticTherapeutic InterventionTimeToxic effectUltrasonographyWorld Health Organizationacute toxicityantagonistbehavior testblindchannel blockerschemical threatcholinergiccholinergic neuroncognitive developmentcognitive functioncompare effectivenesscytokinedensitydesigneffective therapyfetalimprovedin vivoinfant deathinterdisciplinary approachmalemethoctraminemortalitymyometriumneuroinflammationneurotoxicityoffspringpesticide intoxicationpesticide poisoningpostnatalpostnatal developmentpregnantpresynapticpreventresponsetherapeutically effectivevoltage
项目摘要
ABSTRACT
Poisoning with organophosphorus (OP) pesticides during gestation is a life-threatening condition for both
mothers and fetuses. Treatment relies heavily on the use of high doses of atropine to block muscarinic
receptor overactivation by acetylcholine (ACh) build up due to OP-induced block of acetylcholinesterase
(AChE). However, despite therapeutic intervention spontaneous miscarriages, infant and/or maternal deaths,
and postnatal neurological complications (including seizures and cognitive deficits) can ensue. Although rarely
taken into account, the non-selective inhibition of all muscarinic receptor (mAChR) subtypes by atropine may
be an important determinant of these poor outcomes. Specifically, inhibition of presynaptic mAChRs (mostly
M2), which are part of a negative feedback loop that limits ACh release from cholinergic neurons, can
exacerbate the OP-induced cholinergic crisis. The pharmacological profile of R,S-trihexyphenidyl (THP), a drug
that has been safely used during pregnancy and is approved for treatment dystonia and Parkinson’s disease,
makes it an attractive candidate to treat gestational OP poisoning. In contrast to atropine, THP more selectively
inhibits M1 and M3 than M2 mAChRs. In addition, THP inhibits as-of-yet unidentified subtypes of neuronal
nicotinic ACh receptors (nAChRs). Overactivation of M1/M3 mAChRs and neuronal nAChRs in the placenta
and myometrium, and in the cardiorespiratory and nervous systems can contribute to poor health outcomes
following acute OP intoxication during pregnancy. Thus, this project will test the hypothesis that, in part by
sparing M2 mAChRs and potentially by blocking nAChRs in addition to M1/M3 mAChRs, THP will be
more potent and efficacious than atropine to treat gestational OP poisoning. The focus will be on
chlorpyrifos (CPF), a widely used OP pesticide currently included in the U.S. Department of Homeland Security
Chemical Threat Risk Assessment list of chemicals that may be deployed to poison large numbers of people in
terrorist attacks. A multidisciplinary approach, a translationally relevant animal model (the guinea pig), and a
placebo-controlled, randomized, blind design that minimizes experimental bias and maximizes scientific rigor
will be used to address three aims. Aims 1 and 2 will establish the effectiveness of THP to save lives, reduce
signs of acute toxicity, and prevent the development of neurological complications in mothers and fetuses
gestationally exposed to a high dose of CPF. Aim 3 will shed light on the mechanisms that contribute to the
toxicity of CPF and the antidotal effectiveness of THP. Successful completion of this project will lay the
groundwork for the development of more effective antidotes to treat acute CPF intoxication during pregnancy.
Identification of therapeutic interventions that can have a positive impact on the health outcomes of populations
acutely intoxicated with OP pesticides lends support to the initiative of the World Health Organization to tackle
the issue of acute OP pesticide intoxication, particularly in the developing world. In addition, it fulfills an unmet
medical need for the effective treatment of victims of a deliberate attack with these pesticides.
抽象的
妊娠期间有机磷 (OP) 农药中毒对孕妇和婴儿来说都会危及生命
母亲和胎儿。治疗很大程度上依赖于使用高剂量的阿托品来阻断毒蕈碱
OP 诱导的乙酰胆碱酯酶阻断导致乙酰胆碱 (ACh) 受体过度激活
(疼痛)。然而,尽管治疗干预导致自然流产、婴儿和/或孕产妇死亡,
产后神经系统并发症(包括癫痫发作和认知缺陷)可能会随之而来。虽然很少
考虑到阿托品对所有毒蕈碱受体 (mAChR) 亚型的非选择性抑制可能
成为这些不良结果的重要决定因素。具体来说,抑制突触前 mAChR(主要是
M2)是限制胆碱能神经元释放乙酰胆碱的负反馈回路的一部分,可以
加剧 OP 引起的胆碱能危机。 R,S-苯海索 (THP) 药物的药理学概况
已在怀孕期间安全使用,并被批准用于治疗肌张力障碍和帕金森病,
使其成为治疗妊娠期 OP 中毒的有吸引力的候选者。与阿托品相比,THP 更具选择性
与 M2 mAChR 相比,对 M1 和 M3 的抑制作用更大。此外,THP 还能抑制尚未确定的神经元亚型
烟碱型乙酰胆碱受体 (nAChR)。胎盘中 M1/M3 mAChR 和神经元 nAChR 过度激活
和子宫肌层以及心肺和神经系统可能导致不良的健康结果
妊娠期间发生急性 OP 中毒后。因此,该项目将检验以下假设:
除了 M1/M3 mAChR 之外,THP 还可以保护 M2 mAChR,并可能通过阻断 nAChR
治疗妊娠期 OP 中毒比阿托品更有效。重点将放在
毒死蜱 (CPF) 是一种广泛使用的 OP 农药,目前已纳入美国国土安全部
化学品威胁风险评估清单,其中列出了可能用于毒害大量人员的化学品
恐怖袭击。多学科方法、转化相关的动物模型(豚鼠)和
安慰剂对照、随机、盲法设计,最大限度地减少实验偏差并最大限度地提高科学严谨性
将用于实现三个目标。目标 1 和 2 将确定 THP 在拯救生命、减少
急性毒性迹象,并防止母亲和胎儿出现神经系统并发症
妊娠期暴露于高剂量的 CPF。目标 3 将阐明有助于实现这一目标的机制
CPF 的毒性和 THP 的解毒效果。该项目的顺利完成将为
为开发更有效的解毒剂来治疗妊娠期间急性 CPF 中毒奠定基础。
确定可以对人群健康结果产生积极影响的治疗干预措施
OP农药严重中毒者支持世界卫生组织解决这一问题的倡议
急性有机磷农药中毒问题,特别是在发展中国家。此外,它还完成了一个未满足的
对这些农药故意攻击的受害者进行有效治疗的医疗需求。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gestational exposures to organophosphorus insecticides: From acute poisoning to developmental neurotoxicity.
妊娠暴露于有机磷杀虫剂:从急性中毒到发育神经毒性。
- DOI:10.1016/j.neuropharm.2020.108271
- 发表时间:2020-12-01
- 期刊:
- 影响因子:4.7
- 作者:Todd SW;Lumsden EW;Aracava Y;Mamczarz J;Albuquerque EX;Pereira EFR
- 通讯作者:Pereira EFR
Learning and memory retention deficits in prepubertal guinea pigs prenatally exposed to low levels of the organophosphorus insecticide malathion.
- DOI:10.1016/j.ntt.2020.106914
- 发表时间:2020-09
- 期刊:
- 影响因子:2.9
- 作者:Lumsden EW;McCowan L;Pescrille JD;Fawcett WP;Chen H;Albuquerque EX;Mamczarz J;Pereira EFR
- 通讯作者:Pereira EFR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAO P GULLAPALLI其他文献
RAO P GULLAPALLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAO P GULLAPALLI', 18)}}的其他基金
Personalized Motion Management for Truly 4D Lung Radiotherapy
真正 4D 肺部放射治疗的个性化运动管理
- 批准号:
10452607 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Personalized Motion Management for Truly 4D Lung Radiotherapy
真正 4D 肺部放射治疗的个性化运动管理
- 批准号:
10274050 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Targeting M1/M3 Muscarinic Receptors to Treat Gestational Pesticide Poisoning
靶向 M1/M3 毒蕈碱受体治疗妊娠期农药中毒
- 批准号:
10287091 - 财政年份:2018
- 资助金额:
$ 53.14万 - 项目类别:
Traumatic Brain Injury Data for FITBIR Informatics system
FITBIR 信息学系统的创伤性脑损伤数据
- 批准号:
8745266 - 财政年份:2014
- 资助金额:
$ 53.14万 - 项目类别:
Augmented Reality Head Mounted Display for Magnetic Resonance Imaging Guided Inte
用于磁共振成像引导互联网的增强现实头戴式显示器
- 批准号:
8524685 - 财政年份:2013
- 资助金额:
$ 53.14万 - 项目类别:
Augmented Reality Head Mounted Display for Magnetic Resonance Imaging Guided Inte
用于磁共振成像引导互联网的增强现实头戴式显示器
- 批准号:
8675807 - 财政年份:2013
- 资助金额:
$ 53.14万 - 项目类别:
Small Animal Positron Emission Tomography for Translational Research
用于转化研究的小动物正电子发射断层扫描
- 批准号:
7389787 - 财政年份:2007
- 资助金额:
$ 53.14万 - 项目类别:
ADVANCED FUNCTIONAL MRI EQUIPMENT FOR 3 TESLA SYSTEM: SCHIZOPHRENIA
适用于 3 Tesla 系统的先进功能 MRI 设备:精神分裂症
- 批准号:
7334963 - 财政年份:2006
- 资助金额:
$ 53.14万 - 项目类别:
ADVANCED FUNCTIONAL MRI EQUIPMENT FOR 3 TESLA SYSTEM: ADHD
适用于 3 特斯拉系统的先进功能 MRI 设备:ADHD
- 批准号:
7334965 - 财政年份:2006
- 资助金额:
$ 53.14万 - 项目类别:
相似海外基金
Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
- 批准号:
10739853 - 财政年份:2023
- 资助金额:
$ 53.14万 - 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
- 批准号:
10772738 - 财政年份:2023
- 资助金额:
$ 53.14万 - 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
- 批准号:
10303546 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
- 批准号:
10378934 - 财政年份:2021
- 资助金额:
$ 53.14万 - 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
- 批准号:
2480200 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
- 批准号:
9977281 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
- 批准号:
10238898 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
- 批准号:
18K15850 - 财政年份:2018
- 资助金额:
$ 53.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
- 批准号:
481759-2015 - 财政年份:2015
- 资助金额:
$ 53.14万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
- 批准号:
8735550 - 财政年份:2014
- 资助金额:
$ 53.14万 - 项目类别:














{{item.name}}会员




